As a tumor suppressor, FOXA1 targets PIK3R1 and inhibits the PI3K/Akt signaling pathway, which plays an inhibitory role in the proliferation, migration, and invasion of male HCC patients [130]. This evidence concerns the gene FOXA1 and hepatocellular carcinoma.